UChicago Medicine physician-scientists aimed to find out how the immune systems of children with a type of cancer called neuroblastoma respond to tumors. The answer to this question could help guide the treatment of pediatric patients.
Researchers from Roswell Park Comprehensive Cancer Center and the University of Chicago Medicine Comprehensive Cancer Center are combining efforts after together securing a nearly $9 million grant from the National Cancer Institute (NCI) to develop new and better treatments for ovarian cancer.
A study published in the June 10, 2021 issue of Cell describes a remarkable new mechanism by which the body’s own immune system can eliminate cancer cells without damaging host cells. The findings have the potential to develop first-in-class medicines that are designed to be selective for cancer cells and non-toxic to normal cells and tissues.
A $10 million grant from the AbbVie Foundation will support scientific and educational activities at the University of Chicago Medicine Comprehensive Cancer Center under the leadership of a newly appointed Cancer Center Director Kunle Odunsi, MD, PhD.
Adekunle “Kunle” Odunsi, MD, PhD, FRCOG, FACOG, an expert in immunotherapy and vaccine therapy for cancer, has been appointed director of the University of Chicago Medicine Comprehensive Cancer Center. He comes to Chicago from Buffalo, New York, where he served as deputy director at Roswell Park Comprehensive Cancer Center.
Solis Mammography, the nation’s largest independent provider of breast health and diagnostic services, is expanding access to 3D mammography and diagnostic breast health procedures through a partnership with University of Chicago Medicine.
Researchers are beginning to understand more about how to treat a rare but deadly type of blood cancer known as Philadelphia chromosome-negative myeloproliferative neoplasms.
Researchers at the University of Chicago Medicine Comprehensive Cancer Center, working with colleagues in Europe, created a deep learning algorithm that can infer molecular alterations directly from routine histology images across multiple common tumor types. The findings were published July 27 in Nature Cancer.
Pediatric sedation service at the University of Chicago Medicine Comer Children’s Hospital provides a critical bridge for children undergoing medical procedures. It’s one of only nine programs in the United States to be designated a Center of Excellence by the Society of Pediatric Sedation.
The HPV vaccine protects against some of the deadliest, most disfiguring and hard-to-treat cancers. Here is what parents of teens and pre-teens should know about the HPV vaccine.
The University of Chicago Medicine’s Xavier Keutgen, MD, one of the few surgeons in the country with advanced expertise in extensive removal of neuroendocrine tumors, talks about this rare disease.
New research shows how a simple blood test can better identify which patients with diffuse large B cell lymphoma are at risk for relapse.
Eighty-four University of Chicago Medicine physicians were acknowledged for being at the forefront of cancer care by being named to Chicago magazine’s 2019 list of top cancer doctors – the most of any Chicago-area health system.